{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:20:21Z","timestamp":1787800821796,"version":"build-2784847793"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,27]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Obesity is a global epidemic and is increasingly recognized as a direct and independent risk factor for chronic kidney disease (CKD), beyond its established associations with diabetes and hypertension. Excess adiposity promotes kidney injury through convergent hemodynamic, metabolic, and inflammatory pathways, including glomerular hyperfiltration, podocyte stress, lipotoxicity, insulin resistance, activation of the renin\u2013angiotensin system, and chronic low-grade inflammation. Given the rise in the prevalence of obesity and kidney disease driven by obesity as a primary risk factor, there is a critical need to understand emerging treatment options, including novel incretin-based therapies, to prevent disease progression and decrease cardiovascular burden, which is the leading cause of morbidity and mortality in these patients. We aim to review current treatment standards and discuss novel developments in the pathophysiology, diagnosis, outcome prediction, and management of obesity as a risk factor for kidney injury and CKD.<\/jats:p>","DOI":"10.1093\/ndt\/gfag164","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:36:31Z","timestamp":1784028991000},"page":"1618-1628","source":"Crossref","is-referenced-by-count":0,"title":["Risk factor obesity: treatment standard"],"prefix":"10.1093","volume":"41","author":[{"given":"Mahtab","family":"Mashayekhi","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Loma Linda University Medical Center , Loma Linda ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Qing","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine , Hangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giv","family":"Heidari-Bateni","sequence":"additional","affiliation":[{"name":"Loma Linda University, School of Medicine, Loma Linda ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5582-3165","authenticated-orcid":false,"given":"Roy O","family":"Mathew","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Loma Linda VA Healthcare System , Loma Linda ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0963-6270","authenticated-orcid":false,"given":"Adrian","family":"Liew","sequence":"additional","affiliation":[{"name":"Mount Elizabeth Novena Hospital ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kronbichler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck , Innsbruck ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0976-5478","authenticated-orcid":false,"given":"Edgar","family":"Lerma","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Advocate Christ Medical Center, University of Illinois at Chicago , Oak Lawn ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Abdipour","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Loma Linda University Medical Center , Loma Linda ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Codorniz","sequence":"additional","affiliation":[{"name":"Diabetes Treatment Center, Loma Linda University , Loma Linda ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine , Hangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-4959","authenticated-orcid":false,"given":"Sayna","family":"Norouzi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Loma Linda University Medical Center , Loma Linda ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"2026082623121747500_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrneph.2016.75","article-title":"Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis","volume":"12","author":"D\u2019Agati","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"2026082623121747500_bib2","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.2147\/DMSO.S433649","article-title":"The new challenge of obesity-obesity-associated nephropathy","volume":"17","author":"Hao","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2026082623121747500_bib3","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1111\/dme.70042","article-title":"Obesity-related glomerulopathy: how it happens and future perspectives","volume":"42","author":"Lee-Boey","year":"2025","journal-title":"Diabet Med"},{"key":"2026082623121747500_bib4","doi-asserted-by":"crossref","first-page":"e13450","DOI":"10.1111\/obr.13450","article-title":"Obesity-related glomerulopathy: current approaches and future perspectives","volume":"23","author":"Mart\u00ednez-Montoro","year":"2022","journal-title":"Obes Rev"},{"key":"2026082623121747500_bib5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026082623121747500_bib6","doi-asserted-by":"publisher","first-page":"1179834","DOI":"10.3389\/fmed.2023.1179834","article-title":"Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate \u201cdiseased\u201d from \u201cnormal\u201d","volume":"10","author":"Kataoka","year":"2023","journal-title":"Front Med"},{"key":"2026082623121747500_bib7","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/ndt\/gfae027","article-title":"Glomerular hyperfiltration as a therapeutic target for CKD","volume":"39","author":"Kanbay","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026082623121747500_bib8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.kint.2025.09.019","article-title":"The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"109","author":"Furth","year":"2026","journal-title":"Kidney Int"},{"key":"2026082623121747500_bib9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1046\/j.1523-1755.2001.00804.x","article-title":"Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients","volume":"60","author":"Kaysen","year":"2001","journal-title":"Kidney Int"},{"key":"2026082623121747500_bib10","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1681\/ASN.0000000512","article-title":"ASN kidney health guidance on the management of obesity in persons living with kidney diseases","volume":"35","author":"Ikizler","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026082623121747500_bib11","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2215\/CJN.01370210","article-title":"Obesity-related glomerulopathy: body mass index and proteinuria","volume":"5","author":"Shen","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026082623121747500_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/healthcare14010051","article-title":"Translational lifestyle medicine approaches to cardiovascular\u2013kidney\u2013metabolic syndrome","volume":"14","author":"Papadakis","year":"2026","journal-title":"Healthcare"},{"key":"2026082623121747500_bib13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1037\/amp0000517","article-title":"Lifestyle modification approaches for the treatment of obesity in adults","volume":"75","author":"Wadden","year":"2020","journal-title":"Am Psychol"},{"key":"2026082623121747500_bib14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S2213-8587(23)00385-6","article-title":"5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study","volume":"12","author":"Lean","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082623121747500_bib15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/CIRCULATIONAHA.115.018585","article-title":"Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"2026082623121747500_bib16","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1038\/s41440-024-01852-y","article-title":"Obstructive sleep apnea-related hypertension: a review of the literature and clinical management strategy","volume":"47","author":"Shiina","year":"2024","journal-title":"Hypertens Res"},{"key":"2026082623121747500_bib17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s12020-024-03757-9","article-title":"Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future","volume":"84","author":"Caruso","year":"2024","journal-title":"Endocrine"},{"key":"2026082623121747500_bib18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"2026082623121747500_bib19","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","article-title":"Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial","volume":"30","author":"Colhoun","year":"2024","journal-title":"Nat Med"},{"key":"2026082623121747500_bib20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/medicina55060233","article-title":"GLP-1 receptor agonists and kidney protection","volume":"55","author":"Greco","year":"2019","journal-title":"Medicina"},{"key":"2026082623121747500_bib21","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1056\/NEJMoa2500969","article-title":"Oral semaglutide at a dose of 25 mg in adults with overweight or obesity","volume":"393","author":"Wharton","year":"2025","journal-title":"N Engl J Med"},{"key":"2026082623121747500_bib22","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1681\/ASN.0000000764","article-title":"Kidney parameters with tirzepatide in obesity with or without type 2 diabetes","volume":"36","author":"Heerspink","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"2026082623121747500_bib23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1053\/j.ajkd.2020.08.016","article-title":"Strategies to treat obesity in patients with CKD","volume":"77","author":"Chintam","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2026082623121747500_bib24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/2042098611429985","article-title":"Does orlistat cause acute kidney injury?","volume":"3","author":"Beyea","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"2026082623121747500_bib25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1159\/000335352","article-title":"Naltrexone\/bupropion: an investigational combination for weight loss and maintenance","volume":"4","author":"Makowski","year":"2011","journal-title":"Obes Facts"},{"key":"2026082623121747500_bib26","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s41366-024-01526-2","article-title":"Effect of combined GLP-1 analogue and bupropion\/naltrexone on weight loss: a retrospective cohort study","volume":"48","author":"Naude","year":"2024","journal-title":"Int J Obes"},{"key":"2026082623121747500_bib27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26","author":"Neeland","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026082623121747500_bib28","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1161\/CIRCULATIONAHA.124.067676","article-title":"Muscle mass and glucagon-like peptide-1 receptor agonists: adaptive or maladaptive response to weight loss?","volume":"150","author":"Linge","year":"2024","journal-title":"Circulation"},{"key":"2026082623121747500_bib29","doi-asserted-by":"publisher","first-page":"e029282","DOI":"10.1161\/JAHA.122.029282","article-title":"Role of glucagon-like peptide-1 receptor agonists in achieving weight loss and improving cardiovascular outcomes in people with overweight and obesity","volume":"12","author":"Michos","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026082623121747500_bib30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40265-019-1057-0","article-title":"Emerging role of SGLT-2 inhibitors for the treatment of obesity","volume":"79","author":"Pereira","year":"2019","journal-title":"Drugs"},{"key":"2026082623121747500_bib31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S2213-8587(23)00321-2","article-title":"Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial","volume":"12","author":"Staplin","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082623121747500_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00125-025-06565-6","article-title":"Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies","volume":"69","author":"Colombijn","year":"2026","journal-title":"Diabetologia"},{"key":"2026082623121747500_bib33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.kint.2016.12.034","article-title":"Obesity and kidney disease: from population to basic science and the search for new therapeutic targets","volume":"92","author":"Whaley-Connell","year":"2017","journal-title":"Kidney Int"},{"key":"2026082623121747500_bib34","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1681\/ASN.2010090969","article-title":"ACE inhibition is renoprotective among obese patients with proteinuria","volume":"22","author":"Mallamaci","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026082623121747500_bib35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10157-025-02804-7","article-title":"Obesity-related glomerulopathy, a growing kidney burden in the obesity pandemic","volume":"30","author":"Mashayekhi","year":"2026","journal-title":"Clin Exp Nephrol"},{"key":"2026082623121747500_bib36","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"2026082623121747500_bib37","doi-asserted-by":"publisher","first-page":"e1889","DOI":"10.1016\/j.jacc.2026.03.056","article-title":"2026 AHA\/ACC\/ADA\/ASN guideline for the prevention, detection, evaluation, and management of cardiovascular-kidney-metabolic syndrome: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"87","author":"Ndumele","year":"2026","journal-title":"JACC"},{"key":"2026082623121747500_bib38","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.3390\/ijms24043427","article-title":"Endothelin receptor antagonists in kidney disease","volume":"24","author":"Mart\u00ednez-D\u00edaz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026082623121747500_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11695-022-06332-1","article-title":"2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery","volume":"33","author":"Eisenberg","year":"2023","journal-title":"Obes Surg"},{"key":"2026082623121747500_bib40","doi-asserted-by":"publisher","first-page":"e70109","DOI":"10.1002\/osp4.70109","article-title":"Relationships between metabolic and bariatric surgery and adverse kidney outcomes: an analysis of a retrospective cohort","volume":"11","author":"Maki","year":"2025","journal-title":"Obes Sci Pract"},{"key":"2026082623121747500_bib41","doi-asserted-by":"publisher","first-page":"e0163907","DOI":"10.1371\/journal.pone.0163907","article-title":"Effects of bariatric surgery on renal function in obese patients: a systematic review and meta analysis","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"2026082623121747500_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1681\/ASN.0000000797","article-title":"Measurement, estimation, and correlates of the glomerular filtration rate before and after bariatric surgery","volume":"37","author":"Friedman","year":"2026","journal-title":"J Am Soc Nephrol"},{"key":"2026082623121747500_bib43","doi-asserted-by":"publisher","first-page":"e200087","DOI":"10.1001\/jamasurg.2020.0087","article-title":"Comparing the 5-year diabetes outcomes of sleeve gastrectomy and gastric bypass: the National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study","volume":"155","author":"McTigue","year":"2020","journal-title":"JAMA Surg"},{"key":"2026082623121747500_bib44","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.1152\/ajpendo.00179.2022","article-title":"Obesity and chronic kidney disease","volume":"324","author":"Jiang","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026082623121747500_bib45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","article-title":"The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease","volume":"14","author":"Yang","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2026082623121747500_bib46","doi-asserted-by":"publisher","first-page":"740636","DOI":"10.3389\/fphar.2021.740636","article-title":"Possible benefits of faecalibacterium prausnitzii for obesity-associated gut disorders","volume":"12","author":"Maioli","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026082623121747500_bib47","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.3748\/wjg.v27.i25.3837","article-title":"Gut microbiota in obesity","volume":"27","author":"Liu","year":"2021","journal-title":"World J Gastroenterol"},{"key":"2026082623121747500_bib48","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/febs.17249","article-title":"Obesity and the gut microbiota: implications of neuroendocrine and immune signaling","volume":"292","author":"Roman\u00ed-P\u00e9rez","year":"2025","journal-title":"FEBS J"},{"key":"2026082623121747500_bib49","doi-asserted-by":"publisher","first-page":"2328320","DOI":"10.1080\/0886022X.2024.2328320","article-title":"Gut microbiota in the association between obesity and kidney function decline: a metagenomics-based study in a rat model","volume":"46","author":"Alemasi","year":"2024","journal-title":"Ren Fail"},{"key":"2026082623121747500_bib50","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12967-024-04974-6","article-title":"Gut microbial metabolites SCFAs and chronic kidney disease","volume":"22","author":"He","year":"2024","journal-title":"J Transl Med"},{"key":"2026082623121747500_bib51","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3390\/nu13041244","article-title":"Short-chain fatty acids, maternal microbiota and metabolism in pregnancy","volume":"13","author":"Zi\u0119tek","year":"2021","journal-title":"Nutrients"},{"key":"2026082623121747500_bib52","doi-asserted-by":"publisher","first-page":"2436949","DOI":"10.1080\/19490976.2024.2436949","article-title":"Dietary inulin ameliorates obesity-induced severe acute pancreatitis via gut-pancreas axis","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"2026082623121747500_bib53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/19490976.2019.1674124","article-title":"Diversification of host bile acids by members of the gut microbiota","volume":"11","author":"Winston","year":"2020","journal-title":"Gut Microbes"},{"key":"2026082623121747500_bib54","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s42255-024-01072-1","article-title":"Ketogenic diet-induced bile acids protect against obesity through reduced calorie absorption","volume":"6","author":"Li","year":"2024","journal-title":"Nat Metab"},{"key":"2026082623121747500_bib55","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1093\/ckj\/sfac154","article-title":"Decreasing microbiota-derived uremic toxins to improve CKD outcomes","volume":"15","author":"Beker","year":"2022","journal-title":"Clin Kidney J"},{"key":"2026082623121747500_bib56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/17512433.2018.1378095","article-title":"Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease","volume":"11","author":"Prokopienko","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2026082623121747500_bib57","doi-asserted-by":"publisher","first-page":"1097596","DOI":"10.3389\/fendo.2023.1097596","article-title":"Visceral fat and attribute-based medicine in chronic kidney disease","volume":"14","author":"Kataoka","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026082623121747500_bib58","doi-asserted-by":"publisher","first-page":"e13656","DOI":"10.1111\/obr.13656","article-title":"Risk of incident chronic kidney disease in metabolically healthy obesity and metabolically unhealthy normal weight: a systematic review and meta-analysis","volume":"25","author":"Iqbal","year":"2024","journal-title":"Obes Rev"},{"key":"2026082623121747500_bib59","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.orcp.2024.03.005","article-title":"Renal sinus fat is associated with intrarenal hemodynamic abnormalities independent of visceral fat in patients with chronic kidney disease","volume":"18","author":"Kaneko","year":"2024","journal-title":"Obes Res Clin Pract"},{"key":"2026082623121747500_bib60","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12882-021-02531-7","article-title":"The risk of chronic kidney disease in relation to anthropometric measures of obesity: a Swedish cohort study","volume":"22","author":"Memarian","year":"2021","journal-title":"BMC Nephrol"},{"key":"2026082623121747500_bib61","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.0000000000000117","article-title":"Change in albuminuria and GFR slope as joint surrogate end points for kidney failure: implications for phase 2 clinical trials in CKD","volume":"34","author":"Heerspink","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026082623121747500_bib62","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/oby.2009.96","article-title":"Potential contribution of adipose tissue to elevated serum cystatin C in human obesity","volume":"17","author":"Naour","year":"2009","journal-title":"Obesity"},{"key":"2026082623121747500_bib63","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"2026082623121747500_bib64","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1053\/j.ajkd.2023.08.021","article-title":"Modification of association of cystatin C with kidney and cardiovascular outcomes by obesity","volume":"83","author":"Chen","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"2026082623121747500_bib65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/diagnostics15020169","article-title":"Obesity-related chronic kidney disease: from diagnosis to treatment","volume":"15","author":"Avgoustou","year":"2025","journal-title":"Diagnostics"},{"key":"2026082623121747500_bib66","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","article-title":"Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial","volume":"30","author":"Sanyal","year":"2024","journal-title":"Nat Med"},{"key":"2026082623121747500_bib67","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.ekir.2025.03.049","article-title":"The effect of retatrutide on kidney parameters in participants with type 2 diabetes mellitus and\/or obesity","volume":"10","author":"Heerspink","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026082623121747500_bib68","doi-asserted-by":"publisher","first-page":"151408","DOI":"10.1016\/j.semnephrol.2023.151408","article-title":"Gut microbiota-targeted interventions in the management of chronic kidney disease","volume":"43","author":"Sumida","year":"2023","journal-title":"Semin Nephrol"},{"key":"2026082623121747500_bib69","doi-asserted-by":"publisher","first-page":"6755","DOI":"10.3390\/ijms24076755","article-title":"The role of next-generation probiotics in obesity and obesity-associated disorders: current knowledge and future perspectives","volume":"24","author":"Vallianou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026082623121747500_bib70","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.nupar.2025.06.002","article-title":"Effect of dietary fiber on obese\/overweight persons and its mechanism of action: a systematic and meta-analysis on randomized controlled trials","volume":"39","author":"Sharma","year":"2025","journal-title":"Nutr Clin Metab"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag164\/68771185\/gfag164.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/9\/1618\/68771185\/gfag164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/9\/1618\/68771185\/gfag164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:12:49Z","timestamp":1787800369000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/9\/1618\/8733955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":70,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,7,14]]},"published-print":{"date-parts":[[2026,8,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag164","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,7,14]]}}}